Colgate Palmolive
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Colgate Palmolive sits in the top decile of US sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count).
Colgate Palmolive: 51 sponsored US clinical trials, 3 recruiting.
Colgate Palmolive sponsors 51 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 45 completed. 38 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gingivitis, with 3 trials.
Top-decile sponsor footprint
Colgate Palmolive ranks in the top decile of sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
45 of 45 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 5 |
| Phase 3 | 29 |
| Phase 4 | 9 |
Therapeutic Areas
Where Colgate Palmolive enrollment is open (later-stage tilt)
3 recruiting of 51 indexed (6% open); 45 completed (88%).
Phase mix: 38 late (III/IV) vs 6 early (I/II) (later-stage heavy).
Top condition: Gingivitis (3 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Colgate Palmolive: open-pipeline peers nationwide
Peers matched on 51 registered trials and 6% open enrollment, not the therapeutic-area sidebar.
Colgate Palmolive sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 51 trials (± recruiting share)
- MedtronicNeuro · 51 trials · 4% recruiting
- Ohio University · 51 trials · 10% recruiting
- Reproductive Medicine Associates of New Jersey · 51 trials · 14% recruiting
- Texas Woman's University · 51 trials · 6% recruiting
Sponsors near 6% open enrollment (± trial volume)
- BioDelivery Sciences International · 6% recruiting · 17 trials
- Durham VA Medical Center · 6% recruiting · 17 trials
- Essentia Health · 6% recruiting · 17 trials
- Madrigal Pharmaceuticals · 6% recruiting · 17 trials
Related
What to do with this Colgate Palmolive page
51 registered trials is a research-attention snapshot, not an endorsement of Colgate Palmolive or any single study.
- 3 of Colgate Palmolive's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Gingivitis is the condition Colgate Palmolive studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gingivitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Colgate Palmolive pipeline card: 51 registered trials from official public datasets.Report a data error.